SYRETTA MCGRAW: Open Payments
NPI 1083203590 · FT CARSON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 8 payments from 5 companies in 2025. Trend: 2023 $260 · 2024 $205 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $283 |
| E.R. Squibb & Sons, L.L.C. | 1 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: ARISTADA, LYBALVI, COBENFY, CAPLYTA, LOREEV XR, INGREZZA.
Industry payments across CO — which companies pay providers there.
